MAYO CLINIC ROCHESTER
Radiation synthetic combinations in high-risk Ewing sarcoma
Radiation synthetic combinations in high-risk Ewing sarcoma is a funding opportunity from MAYO CLINIC ROCHESTER, up to 659028, closing April 30, 2031.
Apr 30, 2031
(1734d left)Overview
This proposal addresses the interplay of key facets of pediatric cancer research: DNA damage, chromatin accessibility, and the immune response to tumors. The overarching scientific goal of this R01 proposal is to better understand and treat Ewing tumors with STAG2 (stromal antigen 2) loss, a group of Ewing tumors…